Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
PLoS One. 2013 May 23;8(5):e64196. doi: 10.1371/journal.pone.0064196. Print 2013.
It is well established that the cytosine deaminase APOBEC3G can restrict HIV-1 virions in the absence of the virion infectivity factor (Vif) by inducing genome mutagenesis through deamination of cytosine to uracil in single-stranded HIV-1 (-)DNA. However, whether APOBEC3G is able to restrict HIV-1 using a deamination-independent mode remains an open question. In this report we use in vitro primer extension assays on primer/templates that model (-)DNA synthesis by reverse transcriptase from the primer binding site (PBS) and within the protease gene of HIV-1. We find that APOBEC3G is able to decrease the initiation of DNA synthesis by reverse transcriptase approximately 2-fold under conditions where reverse transcriptase is in excess to APOBEC3G, as found in HIV-1 virions. However, the delay in the initiation of DNA synthesis on RNA templates up to 120 nt did not decrease the total amount of primer extended after extended incubation unless the concentration of reverse transcriptase was equal to or less than that of APOBEC3G. By determining apparent Kd values of reverse transcriptase and APOBEC3G for the primer/templates and of reverse transcriptase binding to APOBEC3G we conclude that APOBEC3G is able to decrease the efficiency of reverse transcriptase-mediated DNA synthesis by binding to the RNA template, rather than by physically interacting with reverse transcriptase. All together the data support a model in which this deamination-independent mode of APOBEC3G would play a minor role in restricting HIV-1. We propose that the deamination-independent inhibition of reverse transcriptase we observed can be a mechanism used by APOBEC3G to slow down proviral DNA formation and increase the time in which single-stranded (-)DNA is available for deamination by APOBEC3G, rather than a direct mechanism used by APOBEC3G for HIV-1 restriction.
已证实,在不存在病毒感染性因子(Vif)的情况下,胞嘧啶脱氨酶 APOBEC3G 可以通过将胞嘧啶脱氨为单链 HIV-1(-)DNA 中的尿嘧啶,诱导基因组突变,从而限制 HIV-1 病毒。然而,APOBEC3G 是否能够通过非脱氨依赖模式限制 HIV-1 仍然是一个悬而未决的问题。在本报告中,我们使用体外引物延伸测定法,在从引物结合位点(PBS)和 HIV-1 蛋白酶基因内逆转录酶合成模板的模型(-)DNA 上进行测定。我们发现,在 HIV-1 病毒中发现的逆转录酶过量于 APOBEC3G 的情况下,APOBEC3G 可以将逆转录酶起始 DNA 合成的效率降低约 2 倍。然而,在延长孵育时间的情况下,RNA 模板上 DNA 合成的起始延迟不会减少延长后延伸的引物总量,除非逆转录酶的浓度等于或小于 APOBEC3G 的浓度。通过确定引物模板的逆转录酶和 APOBEC3G 的表观 Kd 值以及逆转录酶与 APOBEC3G 的结合,我们得出结论,APOBEC3G 能够通过结合 RNA 模板而不是通过与逆转录酶物理相互作用来降低逆转录酶介导的 DNA 合成效率。总的来说,数据支持一种模型,即 APOBEC3G 的这种非脱氨依赖模式在限制 HIV-1 中作用较小。我们提出,我们观察到的逆转录酶非脱氨依赖性抑制作用可以是 APOBEC3G 用来减缓前病毒 DNA 形成并增加 APOBEC3G 可用于脱氨的单链(-)DNA 时间的机制,而不是 APOBEC3G 用于 HIV-1 限制的直接机制。